Cabaletta Historical Financial Ratios

CABA Stock

USD 3.01 0.59 24.38%

Cabaletta Bio is presently reporting on over 84 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0241, PTB Ratio of 4.13 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Cabaletta Bio financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.

About Cabaletta Financial Ratios Analysis

Cabaletta BioFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Cabaletta Bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Cabaletta financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Cabaletta Bio history.

Cabaletta Bio Financial Ratios Chart

At present, Cabaletta Bio's PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 6.06, whereas Free Cash Flow Yield is forecasted to decline to (0.06).

Dividend Yield Book Value Per Share Payables Turnover Average Inventory Cash Per Share Capital Expenditure Coverage Ratio

Add Fundamental

Dividend Yield

Dividend Yield is Cabaletta Bio dividend as a percentage of Cabaletta Bio stock price. Cabaletta Bio dividend yield is a measure of Cabaletta Bio stock productivity, which can be interpreted as interest rate earned on an Cabaletta Bio investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Average Inventory

The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.

Most ratios from Cabaletta Bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Cabaletta Bio current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.At present, Cabaletta Bio's PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 6.06, whereas Free Cash Flow Yield is forecasted to decline to (0.06).

Cabaletta Bio fundamentals Correlations

	Dividend Yield	Ptb Ratio	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Free Cash Flow Per Share	Roic	Net Income Per Share	Payables Turnover	Cash Per Share	Pocfratio	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio	Return On Tangible Assets	Ev To Free Cash Flow	Earnings Yield	Net Debt To E B I T D A	Current Ratio
Dividend Yield		-0.4	-0.57	-0.05	0.51	0.64	-0.4	0.49	0.08	0.52	-0.12	-0.33	-0.22	-0.81	-0.8	-0.22	0.39	-0.22	0.43	-0.27	-0.39	-0.28	-0.27	0.01	-0.16	-0.24
Ptb Ratio	-0.4		0.82	-0.51	-0.81	-0.75	1.0	-0.81	0.29	-0.92	0.47	0.93	0.79	0.4	0.5	0.8	-0.74	0.83	-0.85	0.84	1.0	0.4	0.84	-0.62	0.58	0.84
Book Value Per Share	-0.57	0.82		-0.46	-0.87	-0.83	0.82	-0.86	-0.2	-0.83	0.38	0.91	0.81	0.56	0.67	0.81	-0.74	0.9	-0.95	0.89	0.82	0.59	0.89	-0.51	0.82	0.61
Free Cash Flow Yield	-0.05	-0.51	-0.46		0.66	0.57	-0.51	0.66	0.24	0.65	-0.46	-0.51	-0.83	0.06	-0.08	-0.83	0.67	-0.52	0.63	-0.77	-0.51	0.18	-0.76	0.98	-0.31	-0.16
Operating Cash Flow Per Share	0.51	-0.81	-0.87	0.66		0.95	-0.81	1.0	0.28	0.96	-0.71	-0.8	-0.93	-0.5	-0.55	-0.93	0.97	-0.82	0.96	-0.93	-0.81	-0.11	-0.93	0.68	-0.51	-0.4
Capex To Depreciation	0.64	-0.75	-0.83	0.57	0.95		-0.75	0.95	0.26	0.93	-0.54	-0.74	-0.84	-0.64	-0.74	-0.84	0.93	-0.69	0.88	-0.83	-0.75	-0.09	-0.83	0.61	-0.39	-0.31
Pb Ratio	-0.4	1.0	0.82	-0.51	-0.81	-0.75		-0.81	0.29	-0.92	0.47	0.93	0.79	0.4	0.5	0.8	-0.74	0.83	-0.85	0.84	1.0	0.4	0.84	-0.62	0.58	0.84
Free Cash Flow Per Share	0.49	-0.81	-0.86	0.66	1.0	0.95	-0.81		0.28	0.96	-0.72	-0.8	-0.94	-0.48	-0.53	-0.94	0.97	-0.83	0.96	-0.93	-0.81	-0.11	-0.93	0.68	-0.52	-0.4
Roic	0.08	0.29	-0.2	0.24	0.28	0.26	0.29	0.28		0.01	-0.3	0.1	-0.27	-0.08	-0.06	-0.26	0.31	-0.15	0.27	-0.23	0.29	0.18	-0.23	0.08	-0.18	0.6
Net Income Per Share	0.52	-0.92	-0.83	0.65	0.96	0.93	-0.92	0.96	0.01		-0.61	-0.85	-0.9	-0.51	-0.59	-0.9	0.92	-0.78	0.91	-0.9	-0.92	-0.15	-0.9	0.72	-0.45	-0.56
Payables Turnover	-0.12	0.47	0.38	-0.46	-0.71	-0.54	0.47	-0.72	-0.3	-0.61		0.37	0.66	0.09	-0.09	0.66	-0.77	0.55	-0.61	0.59	0.47	-0.34	0.59	-0.42	0.14	0.1
Cash Per Share	-0.33	0.93	0.91	-0.51	-0.8	-0.74	0.93	-0.8	0.1	-0.85	0.37		0.81	0.47	0.54	0.82	-0.71	0.93	-0.89	0.88	0.93	0.56	0.89	-0.59	0.78	0.77
Pocfratio	-0.22	0.79	0.81	-0.83	-0.93	-0.84	0.79	-0.94	-0.27	-0.9	0.66	0.81		0.23	0.37	1.0	-0.92	0.85	-0.94	0.98	0.79	0.1	0.98	-0.84	0.58	0.42
Payout Ratio	-0.81	0.4	0.56	0.06	-0.5	-0.64	0.4	-0.48	-0.08	-0.51	0.09	0.47	0.23		0.82	0.23	-0.43	0.32	-0.44	0.28	0.4	0.3	0.28	-0.01	0.21	0.18
Capex To Operating Cash Flow	-0.8	0.5	0.67	-0.08	-0.55	-0.74	0.5	-0.53	-0.06	-0.59	-0.09	0.54	0.37	0.82		0.37	-0.47	0.35	-0.53	0.42	0.49	0.42	0.42	-0.17	0.31	0.29
Pfcf Ratio	-0.22	0.8	0.81	-0.83	-0.93	-0.84	0.8	-0.94	-0.26	-0.9	0.66	0.82	1.0	0.23	0.37		-0.92	0.86	-0.94	0.99	0.8	0.11	0.98	-0.83	0.6	0.43
Days Payables Outstanding	0.39	-0.74	-0.74	0.67	0.97	0.93	-0.74	0.97	0.31	0.92	-0.77	-0.71	-0.92	-0.43	-0.47	-0.92		-0.75	0.89	-0.88	-0.74	0.08	-0.88	0.68	-0.36	-0.26
Income Quality	-0.22	0.83	0.9	-0.52	-0.82	-0.69	0.83	-0.83	-0.15	-0.78	0.55	0.93	0.85	0.32	0.35	0.86	-0.75		-0.94	0.92	0.83	0.51	0.92	-0.54	0.86	0.65
Roe	0.43	-0.85	-0.95	0.63	0.96	0.88	-0.85	0.96	0.27	0.91	-0.61	-0.89	-0.94	-0.44	-0.53	-0.94	0.89	-0.94		-0.97	-0.84	-0.35	-0.98	0.66	-0.73	-0.53
Ev To Operating Cash Flow	-0.27	0.84	0.89	-0.77	-0.93	-0.83	0.84	-0.93	-0.23	-0.9	0.59	0.88	0.98	0.28	0.42	0.99	-0.88	0.92	-0.97		0.84	0.28	1.0	-0.78	0.71	0.53
Pe Ratio	-0.39	1.0	0.82	-0.51	-0.81	-0.75	1.0	-0.81	0.29	-0.92	0.47	0.93	0.79	0.4	0.49	0.8	-0.74	0.83	-0.84	0.84		0.39	0.84	-0.63	0.58	0.84
Return On Tangible Assets	-0.28	0.4	0.59	0.18	-0.11	-0.09	0.4	-0.11	0.18	-0.15	-0.34	0.56	0.1	0.3	0.42	0.11	0.08	0.51	-0.35	0.28	0.39		0.28	0.11	0.8	0.68
Ev To Free Cash Flow	-0.27	0.84	0.89	-0.76	-0.93	-0.83	0.84	-0.93	-0.23	-0.9	0.59	0.89	0.98	0.28	0.42	0.98	-0.88	0.92	-0.98	1.0	0.84	0.28		-0.78	0.72	0.53
Earnings Yield	0.01	-0.62	-0.51	0.98	0.68	0.61	-0.62	0.68	0.08	0.72	-0.42	-0.59	-0.84	-0.01	-0.17	-0.83	0.68	-0.54	0.66	-0.78	-0.63	0.11	-0.78		-0.31	-0.3
Net Debt To E B I T D A	-0.16	0.58	0.82	-0.31	-0.51	-0.39	0.58	-0.52	-0.18	-0.45	0.14	0.78	0.58	0.21	0.31	0.6	-0.36	0.86	-0.73	0.71	0.58	0.8	0.72	-0.31		0.62
Current Ratio	-0.24	0.84	0.61	-0.16	-0.4	-0.31	0.84	-0.4	0.6	-0.56	0.1	0.77	0.42	0.18	0.29	0.43	-0.26	0.65	-0.53	0.53	0.84	0.68	0.53	-0.3	0.62

Click cells to compare fundamentals

Cabaletta Bio Account Relationship Matchups

High Positive Relationship

Pb Ratio	+ 1.0	Ptb Ratio
Pe Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pe Ratio	+ 1.0	Pb Ratio
Pfcf Ratio	+ 1.0	Pocfratio
Ev To Free Cash Flow	+ 1.0	Ev To Operating Cash Flow

High Negative Relationship

Ev To Free Cash Flow	- 0.98	Roe
Ev To Operating Cash Flow	- 0.97	Roe
Roe	- 0.95	Book Value Per Share
Roe	- 0.94	Income Quality
Roe	- 0.94	Pfcf Ratio
Roe	- 0.94	Pocfratio

Cabaletta Bio fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Ptb Ratio	2.43	2.64	0.83	2.6	3.94	4.13
Book Value Per Share	5.76	4.73	4.58	3.56	5.77	6.06
Free Cash Flow Yield	(0.0499)	(0.0949)	(0.36)	(0.18)	(0.0584)	(0.0613)
Operating Cash Flow Per Share	(0.67)	(1.16)	(1.33)	(1.58)	(1.31)	(1.37)
Pb Ratio	2.43	2.64	0.83	2.6	3.94	4.13
Free Cash Flow Per Share	(0.7)	(1.18)	(1.37)	(1.66)	(1.32)	(1.39)
Roic	0.57	(0.12)	(0.3)	(0.39)	(0.5)	(0.31)
Net Income Per Share	(0.84)	(0.63)	(1.4)	(1.77)	(1.65)	(1.74)
Cash Per Share	5.67	4.69	4.75	3.63	5.89	3.07
Pocfratio	(20.93)	(10.79)	(2.86)	(5.85)	(17.36)	(18.22)
Pfcf Ratio	(20.06)	(10.54)	(2.77)	(5.56)	(17.14)	(17.99)
Income Quality	0.95	0.8	0.74	0.88	0.79	0.61
Roe	(0.11)	(0.3)	(0.39)	(0.5)	(0.29)	(0.27)
Ev To Operating Cash Flow	(12.44)	(7.0)	0.72	(4.2)	(13.84)	(14.53)
Pe Ratio	(22.24)	(8.89)	(2.14)	(5.24)	(13.73)	(14.42)
Ev To Free Cash Flow	(11.92)	(6.84)	0.7	(3.99)	(13.67)	(14.35)
Earnings Yield	(0.045)	(0.11)	(0.47)	(0.19)	(0.0728)	(0.0765)
Net Debt To E B I T D A	7.29	3.03	2.68	1.44	2.57	1.74
Current Ratio	44.66	21.92	14.86	11.47	15.29	22.67
Tangible Book Value Per Share	5.76	4.73	4.58	3.56	5.77	6.06
Graham Number	9.02	12.23	13.51	11.9	14.65	7.44
Shareholders Equity Per Share	5.76	4.73	4.58	3.56	5.77	6.06
Graham Net Net	5.54	4.47	4.42	3.21	5.47	5.74
Enterprise Value Over E B I T D A	(10.68)	(5.6)	0.54	(3.68)	(10.12)	(9.62)
Price Earnings Ratio	(22.24)	(8.89)	(2.14)	(5.24)	(13.73)	(14.42)
Price Book Value Ratio	2.43	2.64	0.83	2.6	3.94	4.13
Price Earnings To Growth Ratio	0.89	(0.0727)	(0.0811)	2.03	1.82	1.91
Price To Operating Cash Flows Ratio	(20.93)	(10.79)	(2.86)	(5.85)	(17.36)	(18.22)
Price To Free Cash Flows Ratio	(20.06)	(10.54)	(2.77)	(5.56)	(17.14)	(17.99)
Effective Tax Rate	0.11	0.0254	0.0164	0.022	0.0253	0.024
Company Equity Multiplier	(3.2)	1.02	1.05	1.07	1.12	1.13
Return On Capital Employed	(0.19)	(0.14)	(0.31)	(0.39)	(0.5)	(0.3)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:

How To Invest In Cabaletta

Details

Is Cabaletta Stock a good investment?

Details

What is Cabaletta Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.

You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.16)

Return On Assets

(0.31)

Return On Equity

(0.48)

The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Cabaletta Historical Financial Ratios

About Cabaletta Financial Ratios Analysis

Cabaletta Bio Financial Ratios Chart

Dividend Yield

Book Value Per Share

Payables Turnover

Average Inventory

Cabaletta Bio fundamentals Correlations

Cabaletta Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cabaletta Bio fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY